Skip to content
Search

Latest Stories

NPA collective action “premature, unnecessary and detrimental to patients” - Stephen Kinnock

Kinnock urged the NPA to reconsider its position and wait for the outcome of negotiations with the Community Pharmacy England (CPE), which he stated would be announced shortly.

Economic analysis of pharmacy finances will be published ‘imminently’ - Stephen Kinnock

Stephen Kinnock also confirms that the outcome of the negotiations with CPE will be announced "very soon."

parliamentlive.tv

Health Minister Stephen Kinnock has announced that the government will be releasing the independent economic analysis of pharmacy finances “imminently.”

Responding to a question from shadow health minister Dr. Luke Evans in Parliament today (25), Kinnock criticised the National Pharmacy Association’s (NPA) collective action as “premature, unnecessary, and detrimental to community pharmacy patients.”


Dr Evans, Conservative MP for Hinckley & Bosworth, questioned whether, following the abolition of NHS England, Kinnock would listen to the calls from the NPA and the Independent Pharmacy Association (IPA) to immediately publish the independent report on pharmacy finances commissioned by NHS England.

Kinnock confirmed that the analysis would be published soon and urged the NPA to reconsider its position and wait for the outcome of negotiations with the Community Pharmacy England (CPE), which he stated would be announced shortly.

“Those negotiations have been very constructive, and I am delighted to confirm again that we will be announcing very soon the outcome of those negotiations,” he said.



Shadow health minister Dr. Luke Evans

However, Dr. Evans argued that community pharmacies have been left waiting too long for answers.

“They are advising all of their 6000 pharmacy members to reduce services and hours for the first time in 104 years. That's never happened under a Labour, Lib Dem, or Conservative government. It's this government.”

He also highlighted the NPA chair’s concerns, stating that “the sense of anger among pharmacy owners has been intensified exponentially by the budget” due to “unfunded National Insurance contributions (NICs) and national living wage increases.”

Dr. Evans then pressed Kinnock on contingency plans for ensuring patient safety if pharmacies close their doors in industrial action next week.

Kinnock accused the shadow minister of “taking the side of people, taking collective action in a premature way that is detrimental to patients.

“They would be better off waiting for the outcome, because we on this side are taking industrial relations into the 21st century, as opposed to the performative nonsense that we saw for the last 14 years,” he said.

Kinnock added: “It's taken us a while to clean up the utter mess that we inherited that involved agreeing financial envelopes and getting into negotiations with the CPE.”

“We're working with CPE on the pharmacy contract, which will start to stabilize the sector and make it fit for the future.”

Kinnock reiterated that this government recognises the vital role of pharmacies as “an integral part of our health system and local community.”

Labour MP for Warrington South, Sarah Hall

Hub and spoke model set to launch later this year

Labour MP for Warrington South, Sarah Hall, questioned the Department of Health and Social Care (DHSC) on the progress of implementing the hub-and-spoke dispensing model for community pharmacy.

Kinnock confirmed that the government intends to introduce draft secondary legislation in the coming weeks, bringing the model into force later this year.

Hall raised concerns about funding uncertainties and financial challenges facing many pharmacies in her constituency.

“With community pharmacy running costs increasing and uncertainty around the date of the upcoming settlement, they are concerned that there may be disruption to their businesses,” she said, asking what steps have been taken to ensure that input from community pharmacies is considered before further legislative or regulatory changes.

Kinnock acknowledged that the community pharmacy system had been “neglected for far too long”, noting that “over the past two years, on average, six pharmacies have closed every week.”

He noted that a wide range of community pharmacies and representative organisations participated in the public consultation on hub-and-spoke reform, and their responses were “overwhelmingly positive” in support of Model 1, which the government will proceed with.

Rishi Sunak, Conservative MP for Richmond and Northallerton

Sunak champions free blood pressure checks in pharmacies

Former prime minister and Conservative MP for Richmond and Northallerton, Rishi Sunak, highlighted the vital role of community pharmacies, referencing a recent visit to a Well Pharmacy in Northallerton.

“Like so many others, it plays an important role in providing community health services. One valued service is the provision of free blood pressure checks to those over the age of 40,” he said, urging Kinnock to encourage more people to take advantage of this free pharmacy-led preventative community health service.

Kinnock emphasised that community pharmacies will play a pivotal role in the government's shift from hospital to community.

He reaffirmed support for the Pharmacy First model, enabling pharmacies to do more clinical work, such as blood pressure checks.

“We absolutely see that as being at the heart of our 10-year plan,” he added.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less